ناشر تخصصی کنفرانس های ایران

لطفا کمی صبر نمایید

Publisher of Iranian Journals and Conference Proceedings

Please waite ..
Publisher of Iranian Journals and Conference Proceedings
Login |Register |Help |عضویت کتابخانه ها
Paper
Title

Prevention, diagnosis and treatment for the new coronavirus, the causative agent of COVID-۱۹

Year: 1399
COI: MEDISM21_231
Language: EnglishView: 37
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

Authors

Razih Rezaei - Shahid Ashrafi Esfahani University
Negar Golpiran - Shahid Ashrafi Esfahani University
Seyed Mahdi Ghasemi - Shahid Ashrafi Esfahani University

Abstract:

Background and Aim : The unprecedented outbreak of new coronavirus in Wuhan, Hubei Province, China, occurred in December ۲۰۱۹. The International Committee on Taxonomy of Viruses (ICTV) named the virus SARS-CoV-۲ because of its similarity to the SARS virus, and the World Health Organization named the disease caused by this virus, COVID-۱۹. The virus is composed of positive sense single-stranded RNA surrounded by capsid proteins and a membrane. Large number of infected individuals exposed to live animals (bats, snakes, marmots, and pangolins) in Wuhan, China, suggested that these animals may be the source of the COVID-۱۹. Extensive measures have been taken to reduce the person-to-person transmission of COVID-۱۹ to control the current outbreak. Special care should be taken to protect or reduce transmission in vulnerable populations, including children, health care providers, and the elderly. The virus can have irreversible effects on human health and cause serious damage to various organs of the body, including the lungs, gastrointestinal tract, kidneys, heart and brain.Methods : In this review study, the ways of transmission and prevention of the new coronavirus and diagnostic methods including PCR test and antibody test and the latest research in the field of treatment and results of using drugs have been discussed.Results : The results revealed that different drugs such as ibuprofen, chloroquine, Viral protease and RNA polymerase inhibitors and plasma therapy had positive effect in recovery of patients. Hopeful results was obtained to design effective vaccine especially RNA vaccine.Conclusion : Several strategy must be used for eradication of COVID-۱۹. Prevention by social distancing, using face mask and herd immunity by vaccination, rapid diagnosis of patients and treatment by effective drugs such as RNA-dependent RNA polymerase (RdRp) could help us to control and eradicate COVID-۱۹

Keywords:

Paper COI Code

This Paper COI Code is MEDISM21_231. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:

https://civilica.com/doc/1254907/

How to Cite to This Paper:

If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:
Rezaei, Razih and Golpiran, Negar and Ghasemi, Seyed Mahdi,1399,Prevention, diagnosis and treatment for the new coronavirus, the causative agent of COVID-۱۹,21th International Congress of Microbiology of Iran,Tehran,https://civilica.com/doc/1254907

Research Info Management

Certificate | Report | من نویسنده این مقاله هستم

اطلاعات استنادی این Paper را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.

Scientometrics

The specifications of the publisher center of this Paper are as follows:
Type of center: موسسه غیرانتفاعی
Paper count: 518
In the scientometrics section of CIVILICA, you can see the scientific ranking of the Iranian academic and research centers based on the statistics of indexed articles.

New Papers

Share this page

More information about COI

COI stands for "CIVILICA Object Identifier". COI is the unique code assigned to articles of Iranian conferences and journals when indexing on the CIVILICA citation database.

The COI is the national code of documents indexed in CIVILICA and is a unique and permanent code. it can always be cited and tracked and assumed as registration confirmation ID.

Support